FDA Adverse Event Injury Summary report: N

XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 1729701 · Received June 16, 2010

Report

Report Number
2024168-2010-01188
Event Type
Injury
Date Received
June 16, 2010
Date of Event
May 18, 2010
Report Date
May 22, 2010
Manufacturer
ABBOTT VASCULAR-CARDIAC THERAPIES
Product Code
NIQ
PMA / PMN Number
P070015
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B) (4). (B) (4). THERE WAS NO REPORTED DEFICIENCY. ANGINA, ISCHEMIA AND STENOSIS ARE KNOWN ADVERSE EVENTS AS LISTED IN THE XIENCE V INSTRUCTIONS FOR USE. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PT EFFECTS AND THE RELATIONSHIP TO THE DEVICE, IF ANY, CANNOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURE, DESIGN, OR LABELING. THE XIENCE V (PART 1009539-28, LOT 8041842), IS BEING FILED UNDER THIS MFR#.

Description of Event or Problem · 1

DEVICE ISSUE: NONE. ADVERSE EVENT: RESTENOSIS REQUIRING INTERVENTION. ONSET OF ADVERSE EVENT: AFTER THE PROCEDURE. IT WAS REPORTED VIA TRIAL THAT ON (B) (6) 2008, THE PT UNDERWENT DIRECT STENTING IN THE PROXIMAL LEFT ANTERIOR DESCENDING ARTERY WITH ONE XIENCE V STENT, THE PREDILATED LEFT DISTAL CIRCUMFLEX ARTERY WITH ONE XIENCE V STENT, AND DIRECT STENTING IN THE SAPHENOUS VEIN GRAFT (SVG) WITH ONE XIENCE V STENT. ON (B) (6) 2010, THE PT HAD A STRESS TEST THAT SHOWED MILD TO MODERATE INFEROLATERAL ISCHEMIA THAT WAS DIAGNOSED AS UNSTABLE ANGINA. THE PT UNDERWENT DIAGNOSTIC CORONARY ANGIOGRAPHY ON (B) (6) 2010; PERCUTANEOUS CORONARY INTERVENTION WITH BALLOON DILATATION ONLY IN THE PROXIMAL LEFT CIRCUMFLEX AND SVG TARGET VESSELS. THE PT'S CONDITION RESOLVED AND THE PT WAS DISCHARGED ON (B) (6) 2010. THERE WAS NO ADDITIONAL INFORMATION PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM NIQ ABBOTT VASCULAR-CARDIAC THERAPIES NA 8052961

Patients

Seq Age Sex Outcome Treatment
1 70 YR Required Intervention XIENCE V (PART 1009542-28, LOT 8022261)| VESSEL CLOSURE: PERCLOSE| STENT: XIENCE V (PART 1009539-28, LOT 8041842)